Next Article in Journal / Special Issue
Preferences for Prenatal Tests for Cystic Fibrosis: A Discrete Choice Experiment to Compare the Views of Adult Patients, Carriers of Cystic Fibrosis and Health Professionals
Previous Article in Journal
Associations between U.S. Adult Obesity and State and County Economic Conditions in the Recession
Previous Article in Special Issue
Women’s Attitudes Regarding Prenatal Testing for a Range of Congenital Disorders of Varying Severity
Article Menu

Export Article

Open AccessArticle
J. Clin. Med. 2014, 3(1), 167-175;

Maternal Germinal Trisomy 21 in Down Syndrome

Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm S-171 76, Sweden
Department of Neurobiology, Care Sciences and Society, KI Alzheimer Disease Research Center, Karolinska University Hospital, Huddinge, Stockholm S-141 86, Sweden
Department of Clinical Genetics, Karolinska University Hospital, Stockholm S-171 76, Sweden
Department of Clinical and Experimental Medicine, Linköping University, LMC, University Hospital, Linköping S-581 85, Sweden
Author to whom correspondence should be addressed.
Received: 20 December 2013 / Revised: 17 January 2014 / Accepted: 20 January 2014 / Published: 28 January 2014
(This article belongs to the Special Issue Prenatal Genetic Screening and Diagnosis-Part 2)
Full-Text   |   PDF [360 KB, uploaded 29 January 2014]   |  


It has now been over 50 years since it was discovered that Down syndrome is caused by an extra chromosome 21, i.e., trisomy 21. In the interim, it has become clear that in the majority of cases, the extra chromosome is inherited from the mother, and there is, in this respect, a strong maternal age effect. Numerous investigations have been devoted to clarifying the underlying mechanism, most recently suggesting that this situation is exceedingly complex, involving both biological and environmental factors. On the other hand, it has also been proposed that germinal trisomy 21 mosaicism, arising during the very early stages of maternal oogenesis with accumulation of trisomy 21 germ cells during subsequent development, may be the main predisposing factor. We present data here on the incidence of trisomy 21 mosaicism in a cohort of normal fetal ovarian samples, indicating that an accumulation of trisomy 21 germ cells does indeed take place during fetal oogenesis, i.e., from the first to the second trimester of pregnancy. We presume that this accumulation of trisomy 21 (T21) cells is caused by their delay in maturation and lagging behind the normal cells. We further presume that this trend continues during the third trimester of pregnancy and postnatally, up until ovulation, thereby explaining the maternal age effect in Down syndrome. View Full-Text
Keywords: aneuploidy; Down syndrome; germinal mosaicism; maternal origin; trisomy 21 aneuploidy; Down syndrome; germinal mosaicism; maternal origin; trisomy 21

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Hultén, M.A.; Öijerstedt, L.; Iwarsson, E.; Jonasson, J. Maternal Germinal Trisomy 21 in Down Syndrome. J. Clin. Med. 2014, 3, 167-175.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
J. Clin. Med. EISSN 2077-0383 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top